Generation Bio (GBIO) Competitors $5.95 +0.36 (+6.44%) Closing price 09/16/2025 04:00 PM EasternExtended Trading$5.90 -0.04 (-0.76%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GBIO vs. NKTX, SCLX, CABA, LFVN, MIST, AVTX, THTX, CHRS, GLSI, and CLLSShould you be buying Generation Bio stock or one of its competitors? The main competitors of Generation Bio include Nkarta (NKTX), Scilex (SCLX), Cabaletta Bio (CABA), Lifevantage (LFVN), Milestone Pharmaceuticals (MIST), Avalo Therapeutics (AVTX), Theratechnologies (THTX), Coherus Oncology (CHRS), Greenwich LifeSciences (GLSI), and Cellectis (CLLS). These companies are all part of the "pharmaceutical products" industry. Generation Bio vs. Its Competitors Nkarta Scilex Cabaletta Bio Lifevantage Milestone Pharmaceuticals Avalo Therapeutics Theratechnologies Coherus Oncology Greenwich LifeSciences Cellectis Nkarta (NASDAQ:NKTX) and Generation Bio (NASDAQ:GBIO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, media sentiment, profitability, risk, institutional ownership and analyst recommendations. Do analysts prefer NKTX or GBIO? Nkarta presently has a consensus price target of $13.60, suggesting a potential upside of 597.44%. Generation Bio has a consensus price target of $10.67, suggesting a potential upside of 79.27%. Given Nkarta's stronger consensus rating and higher possible upside, equities research analysts plainly believe Nkarta is more favorable than Generation Bio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nkarta 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Generation Bio 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has preferable valuation and earnings, NKTX or GBIO? Nkarta has higher earnings, but lower revenue than Generation Bio. Nkarta is trading at a lower price-to-earnings ratio than Generation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNkartaN/AN/A-$108.79M-$1.48-1.32Generation Bio$19.89M2.02-$131.67M-$10.82-0.55 Is NKTX or GBIO more profitable? Nkarta has a net margin of 0.00% compared to Generation Bio's net margin of -341.12%. Nkarta's return on equity of -27.74% beat Generation Bio's return on equity.Company Net Margins Return on Equity Return on Assets NkartaN/A -27.74% -22.38% Generation Bio -341.12%-91.07%-33.65% Which has more volatility & risk, NKTX or GBIO? Nkarta has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500. Comparatively, Generation Bio has a beta of 2.48, indicating that its share price is 148% more volatile than the S&P 500. Do insiders & institutionals hold more shares of NKTX or GBIO? 80.5% of Nkarta shares are owned by institutional investors. Comparatively, 95.2% of Generation Bio shares are owned by institutional investors. 8.4% of Nkarta shares are owned by company insiders. Comparatively, 21.1% of Generation Bio shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media prefer NKTX or GBIO? In the previous week, Generation Bio had 1 more articles in the media than Nkarta. MarketBeat recorded 2 mentions for Generation Bio and 1 mentions for Nkarta. Nkarta's average media sentiment score of 1.91 beat Generation Bio's score of 1.45 indicating that Nkarta is being referred to more favorably in the media. Company Overall Sentiment Nkarta Very Positive Generation Bio Positive SummaryNkarta beats Generation Bio on 10 of the 16 factors compared between the two stocks. Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GBIO vs. The Competition Export to ExcelMetricGeneration BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$37.65M$3.12B$5.73B$10.31BDividend YieldN/A2.36%5.88%4.63%P/E Ratio-0.5521.1676.1526.51Price / Sales2.02446.35523.22123.62Price / CashN/A45.4037.1760.46Price / Book0.469.6213.686.29Net Income-$131.67M-$53.28M$3.29B$270.60M7 Day Performance-0.50%1.01%0.84%1.95%1 Month Performance-5.41%4.58%4.63%6.33%1 Year Performance-77.46%8.35%81.08%25.61% Generation Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GBIOGeneration Bio4.034 of 5 stars$5.95+6.4%$10.67+79.3%-76.1%$37.65M$19.89M-0.55150Positive NewsShort Interest ↓High Trading VolumeNKTXNkarta2.3678 of 5 stars$2.12-6.2%$13.60+541.5%-65.5%$160.51MN/A-1.43140Positive NewsHigh Trading VolumeSCLXScilex2.1994 of 5 stars$22.17-2.8%$455.00+1,952.3%-40.9%$158.59M$56.59M-0.7680Positive NewsCABACabaletta Bio3.0572 of 5 stars$1.68-1.2%$14.50+763.1%-49.5%$155.49MN/A-0.6250Positive NewsLFVNLifevantage3.9784 of 5 stars$11.44-5.5%$30.50+166.6%+7.9%$153.69M$228.53M15.46260High Trading VolumeMISTMilestone Pharmaceuticals2.447 of 5 stars$1.75-2.8%$5.00+185.7%+28.3%$152.99M$1M-2.0830AVTXAvalo Therapeutics3.8953 of 5 stars$11.41-1.6%$30.00+162.9%+9.9%$152.57M$440K0.0040News CoveragePositive NewsShort Interest ↓THTXTheratechnologiesN/A$3.27flatN/A+132.4%$150.35M$85.87M-17.21140News CoverageShort Interest ↓CHRSCoherus Oncology4.3517 of 5 stars$1.37+6.2%$4.51+229.4%+29.5%$149.93M$272.21M0.88330Positive NewsGLSIGreenwich LifeSciences1.5371 of 5 stars$11.17+2.2%$42.00+276.0%-22.0%$148.98MN/A-8.213CLLSCellectis3.3663 of 5 stars$2.74+2.2%$4.00+46.0%+37.4%$148.96M$49.22M-3.34290News CoverageShort Interest ↓ Related Companies and Tools Related Companies NKTX Alternatives SCLX Alternatives CABA Alternatives LFVN Alternatives MIST Alternatives AVTX Alternatives THTX Alternatives CHRS Alternatives GLSI Alternatives CLLS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GBIO) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
